Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Janarthan Nikhil
Effect of Operator and Institutional Volume on Clinical Outcomes After Percutaneous Coronary Interventions Performed in Canada and the United States: A Brief Report From the Enhanced Suppression of the Platelet Glycoprotein IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) Study
Canadian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Related publications
Clinical Significance of Thrombocytopenia During a Non ST-Elevation Acute Coronary Syndrome : The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Experience
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Platelet Inhibition After Glycoprotein IIb/IIIa Inhibitor Therapy
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005-2009)
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Stent Parameters Predict Major Adverse Clinical Events and the Response to Platelet Glycoprotein IIb/IIIa Blockade: Findings of the ESPRIT Trial
Circulation: Cardiovascular Interventions
Cardiovascular Medicine
Cardiology
Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
JAMA - Journal of the American Medical Association
Medicine
Meta-Analysis of Clinical Efficacy and Bleeding Risk With Intravenous Glycoprotein IIb/IIIa Antagonists for Percutaneous Coronary Intervention
Canadian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Glycoprotein IIb/IIIa Induced Coronary Thrombolysis
Heart
Deaths Associated With Platelet Glycoprotein IIb/IIIa Inhibitor Treatment
Heart
